AbbVie to Present at Barclays Global Health Care Conference
Get Alerts ABBV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.5%
Revenue Growth %: +9.7%
Join SI Premium – FREE
NORTH CHICAGO, Ill., March 6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Barclays Global Health Care Conference on Thursday, March 12, 2015. Richard A. Gonzalez, chairman and chief executive officer, will participate in a question and answer session at 8:30 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbvie-to-present-at-barclays-global-health-care-conference-300046563.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbvie (ABBV) PT Raised to $275 at UBS
- Jan Daley Turns Up the Heat With New Uptempo Pop Single “Line of Fire”
- Entera Bio to present EB613 Phase 3 study design at ASBMR meeting
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share